Alcon Urges Dismissal Of Drug Bottle Size Class Action

Law360, New York (May 7, 2013, 3:39 PM EDT) -- Alcon Laboratories Inc. on Monday asked an Illinois federal judge to dismiss a putative class action accusing it of forcing consumers to buy bottles containing more prescription medicine than needed for effective treatment, arguing the plaintiff has no legitimate claim under state law for the federally regulated drugs.

According to the eye treatment specialist, plaintiff Carmen Fields' claim that Alcon only sells anti-inflammatory Nevanac or antibacterials Moxeza and Vigamox in containers with substantially more of the drugs than the typical patient ever uses, unfairly requiring consumers...
To view the full article, register now.




Case Information

Case Title

Fields v. Alcon Laboratories, Inc. et al

Case Number



Illinois Southern

Nature of Suit

Contract: Other


Staci M. Yandle

Date Filed

February 26, 2013

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.